NO954390L - Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner - Google Patents

Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Info

Publication number: NO954390L
Authority: NO; Norway
Prior art keywords: alkyl; amino acid; acyclovir; peptide derivative; combating
Prior art date: 1993-05-03

Application number

NO954390A

Other languages

English (en)

Norwegian (no)

Other versions

NO954390D0 (no

Inventor

James Gus Chafouleas

Robert Deziel

Original Assignee

Bio Mega Boehringer Ingelheim

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-03

Filing date

1995-11-02

Publication date

1996-01-02

1995-11-02 Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim

1995-11-02 Publication of NO954390D0 publication Critical patent/NO954390D0/no

1996-01-02 Publication of NO954390L publication Critical patent/NO954390L/no

Links

MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 title abstract 2
229960004150 aciclovir Drugs 0.000 title abstract 2
208000009889 Herpes Simplex Diseases 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
206010019973 Herpes virus infection Diseases 0.000 abstract 1
125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
230000002155 anti-virotic effect Effects 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
229940127073 nucleoside analogue Drugs 0.000 abstract 1
125000003884 phenylalkyl group Chemical group 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO954390A 1993-05-03 1995-11-02 Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner NO954390L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002095408A CA2095408A1 (en)	1993-05-03	1993-05-03	Method of combating acyclovir-resistant herpes simplex viral infections
PCT/CA1994/000242 WO1994025046A1 (en)	1993-05-03	1994-04-29	Method of combating acyclovir-resistant herpes simplex viral infections

Publications (2)

Publication Number	Publication Date
NO954390D0 NO954390D0 (no)	1995-11-02
NO954390L true NO954390L (no)	1996-01-02

Family

ID=4151571

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO954390A NO954390L (no)	1993-05-03	1995-11-02	Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Country Status (13)

Country	Link
EP (1)	EP0767671A1 (cs)
JP (1)	JPH08509476A (cs)
KR (1)	KR960701651A (cs)
CN (1)	CN1126438A (cs)
AU (1)	AU683465B2 (cs)
BR (1)	BR9406575A (cs)
CA (1)	CA2095408A1 (cs)
CZ (1)	CZ287795A3 (cs)
HU (1)	HUT73779A (cs)
NO (1)	NO954390L (cs)
SG (1)	SG48806A1 (cs)
SK (1)	SK132695A3 (cs)
WO (1)	WO1994025046A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6599887B2 (en)	1988-07-07	2003-07-29	Chimerix, Inc.	Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en)	1988-07-07	2001-06-26	Nexstar Pharmaceuticals, Inc.	Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) *	1988-07-07	1998-10-06	Nexstar Pharmaceuticals, Inc.	Antiviral liponucleosides: treatment of hepatitis B
CA2230750C (en) *	1994-12-28	2002-05-21	Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee	Antiherpes peptidomimetic compounds
CN109627243B (zh) *	2019-01-09	2021-06-29	广西壮族自治区水产科学研究院	一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2033448C (en) *	1990-12-31	1996-11-26	Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee	Antiherpes compositions and method of use
DE69320390T2 (de) *	1992-03-12	1999-02-11	Boehringer Ingelheim (Canada) Ltd., Laval, Quebec	Isosterische Peptidderivate gegen Herpes

1993
- 1993-05-03 CA CA002095408A patent/CA2095408A1/en not_active Abandoned
1994
- 1994-04-29 AU AU66423/94A patent/AU683465B2/en not_active Expired - Fee Related
- 1994-04-29 CZ CZ952877A patent/CZ287795A3/cs unknown
- 1994-04-29 SG SG1996001910A patent/SG48806A1/en unknown
- 1994-04-29 WO PCT/CA1994/000242 patent/WO1994025046A1/en not_active Ceased
- 1994-04-29 KR KR1019950704828A patent/KR960701651A/ko not_active Withdrawn
- 1994-04-29 HU HU9503135A patent/HUT73779A/hu unknown
- 1994-04-29 CN CN94192662A patent/CN1126438A/zh active Pending
- 1994-04-29 BR BR9406575A patent/BR9406575A/pt not_active Application Discontinuation
- 1994-04-29 JP JP6523705A patent/JPH08509476A/ja active Pending
- 1994-04-29 EP EP94914991A patent/EP0767671A1/en not_active Ceased
- 1994-04-29 SK SK1326-95A patent/SK132695A3/sk unknown
1995
- 1995-11-02 NO NO954390A patent/NO954390L/no unknown

Also Published As

Publication number	Publication date
HU9503135D0 (en)	1996-01-29
AU683465B2 (en)	1997-11-13
JPH08509476A (ja)	1996-10-08
NO954390D0 (no)	1995-11-02
CZ287795A3 (en)	1996-06-12
SK132695A3 (en)	1996-10-02
AU6642394A (en)	1994-11-21
KR960701651A (ko)	1996-03-28
BR9406575A (pt)	1996-03-19
EP0767671A1 (en)	1997-04-16
HUT73779A (en)	1996-09-30
CA2095408A1 (en)	1994-11-04
WO1994025046A1 (en)	1994-11-10
SG48806A1 (en)	1998-05-18
CN1126438A (zh)	1996-07-10

Publication	Publication Date	Title
NO960713D0 (no)	1996-02-22	Substituerte azaindolylidenforbindelser og fremgangsmåte for deres fremstilling
HUP0101999A2 (hu)	2001-11-28	4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
NO954390L (no)	1996-01-02	Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner
NO943345L (no)	1994-09-09	Isostere anti-herpes peptid-derivater
DK629889A (da)	1990-06-15	Aminosyrederivater, deres fremstilling og anvendelse som laegemidler
DK0556119T3 (da)	1997-12-15	Pyrrolidinderivater, som i tre-stillingen er substitueret med en mættet eller umættet fedtsyregruppe, fremgangsmåde til deres fremstilling og farmaceutiske præparater med thromboxan-A2-inhibitorisk aktivitet indeholdende dem
NO953437L (no)	1995-09-01	Inhibitorer for Herpes virus ribonukleotid-reduktase
NO921908L (no)	1992-11-17	Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
DE69319266D1 (de)	1998-07-30	Peptidderivate mit einem Ureido-N-Terminus gegen Herpes
RU93004779A (ru)	1997-01-10	Производные пептидов и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция, способ лечения заражений вирусом герпеса
FI944076A7 (fi)	1994-09-05	Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
NO921406L (no)	1992-04-09	Gem-difosfonsyrer, fremgangsmaate ved deres fremstilling og farmasoeytiske sammensetninger som inneholder dem